Skip to content

Exploring the Molecular Mechanism of ITGB2 in IgA Nephropathy

The mechanism of ITGB2 regulating PI3K/AKT signaling pathway to inhibit autophagy involved in the occurrence and development of IgA nephathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126161
Enrollment
Unknown
Registered
2026-06-04
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with renal biopsy-proven IgA nephropathy.

Interventions

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The patient underwent renal biopsy, which confirmed a diagnosis of primary IgA nephropathy; 2.Light microscopy revealed mesangial hypercellularity and matrix expansion; 3.Immunofluorescence showed IgA deposits in the mesangial area, often accompanied by C3 and IgG. Healthy group: 1. healthy patients without abnormal biochemical renal function test, urinary sediment test and proteinuria; 2. the patient's basic information (including gender, age, etc.) and laboratory indicators (blood pressure, serum creatinine, serum cystatin C, blood urea nitrogen, etc.) are complete.

Exclusion criteria

Exclusion criteria: 1.Exclusion of secondary causes of IgA nephropathy, such as Henoch-Schönlein purpura nephritis, lupus nephritis, viral hepatitis-associated nephritis, and diabetic kidney disease; 2.Exclusion of patients who were pregnant, planning to become pregnant; 3.Exclusion of patients with other chronic underlying diseases, including coronary heart disease, essential hypertension, cerebrovascular diseases, etc.

Design outcomes

Primary

MeasureTime frame
Blood cystatin C;Blood Urea Nitrogen;Serum Creatinine;

Countries

China

Contacts

Public ContactYuying Wang

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

644453436@qq.com+86 571 85857860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026